Efficacy and safety of homemade bezafibrate in treatment of hypertriglyceridemia
Luo Leiming,Zhu Qiwei,Zhu Bing,Ma Qin,Zeng Qiang,Yang Xue,Wu Hongmei,Mao Li,Ye Ping
DOI: https://doi.org/10.3969/j.issn.1008-5734.2009.05.001
2009-01-01
Abstract:Objective:To assess the efficacy and safety of homemade bezafibrate in treatment of hypertriglyceridemia. Methods:Form May 2006 to July 2007,132 patients with hypertriglyceridemia were enrolled in the study and randomly divided into the following three groups:the bezafibrate group (59 cases),the fenofibrate group (55 cases),and the control group (18 cases). The bezafibrate group comprised 45 male and 14 female patients with an average age of (51.4±15.4) years. The fenofibrate group comprised 42 male and 13 female patients with an average age of (51.5±15.5) years. The control group comprised 13 male and 5 female patients with an average age of (52.7±16.0) years. The bezafibrate group was administered bezafibrate 200 mg orally thrice daily,the fenofibrate group was administered fenofibrate 100 mg orally thrice daily,the control group received non-drug therapy. The duration of treatment was 3 months. The blood levels of triglyceride,total cholesterol ,low-density lipoprotein cholesterol,and high-density lipoprotein cholesterol were measured before and after therapy and compared among the three groups. The adverse reactions were observed. Results:In the bezafibrate and fenofibrate groups,the levels of TG,TC and LDL-C were respectively(3.16±0.60),(5.25±0.56),(2.76±0.45)and(3.13±0.55),(5.28±0.52),(2.82±0.41)mmol/L before treatment and deceased respectively to (2.42±0.43),(4.93±0.47),(2.55±0.44)and(2.43±0.43),(4.97±0.47),(2.48±0.45)mmol/L after treatment,and the differences were statistically significant (all P<0.01); the levels of HDL-C were respectively (1.09±0.18) and (1.10±0.16) mmol/L before treatment and increased respectively to (1.23±0.13) and (1.22±0.18) mmol/L after treatment,and the differences were statistically significant (all P<0.01). In the control groups,after treatment,the levels of TG,TC,and LDL-C were respcetively (3.10±0.40),(5.22±0.42),and (2.81±0.57)mmol/L,which were higher than those in the bezafibrate group (P<0.05,P<0.01); and the levels of TG and LDL-C were markedly higher than those in the fenofibrate group (P<0.05,P<0.01); HDL-C level was (1.10±0.13)mmol/L,which was markedly lower than that in the bezafibrate and fenofibrate groups(all P<0.05). There was no statistically significant difference in the indices between the two treatment groups (all P> 0.05). In the bezafibrate and fenofibrate groups,gastrointestinal symptoms occurred in 11 cases (18.6%) and 9 cases (16.4%),respectively; there was no statistically significant difference (P> 0.05); Transient elevation of ALT,AST,and CK levels occurred. There were no statistically significant differences in rash and some other adverse reactions between the two treatment groups (all P> 0.05). Conclusion:Homemade bezafibrate is a safe and effective lipid-lowering agent.